Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Oncotarget
|
April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery
Alan H Bryce, Jan B Egan, Mitesh J Borad, et al.
American Journal of Human Genetics
|
February 14, 2017
Public Attitudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey in the US
Saskia C Sanderson, Kyle B Brothers, Nathaniel D Mercaldo, et al.
Mayo Clinic Proceedings
|
January 7, 2014
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, et al.
JCO Precision Oncology
|
February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma
Jan B Egan, David L Marks, Tara L Hogenson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Oncotarget
|
April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery
Alan H Bryce, Jan B Egan, Mitesh J Borad, et al.
American Journal of Human Genetics
|
February 14, 2017
Public Attitudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey in the US
Saskia C Sanderson, Kyle B Brothers, Nathaniel D Mercaldo, et al.
Mayo Clinic Proceedings
|
January 7, 2014
Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, et al.
JCO Precision Oncology
|
February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma
Jan B Egan, David L Marks, Tara L Hogenson, et al.
Page
of 8